Is this your firm? Get featured or correct your listing →
At a glance
Canaan Partners appears in 3 funding rounds tracked by ValueAddVC since 2026, leading 1. Its most recent tracked deal was Solstice Oncology's $225M Series A round (Sep 9, 2026).
Strategy
Recent changes
- Sep 9, 2026Sep 9, 2026Invested in Solstice Oncology (Series A, $225M) GlobeNewswire
- Jul 29, 2026Jul 29, 2026Invested in Mate Security (Series A, $35M) The Next Web
- Apr 7, 2026Apr 7, 2026Invested in Hermeus (Series C, $350M) TechCrunch
Portfolio
3 totalRecent Investment Activity
3Track record: led 1 and participated in 2 of 3 tracked venture rounds · 3 in the last 12 months · led 1 Series A
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Solstice Oncology | Series A | Participated | $225M | — | GlobeNewswire | |
| Jul 29, 2026 | Mate Security | Series A | Led | $35M | — | Canaan PartnersLeadunverifiedInsight PartnersunverifiedTeam8unverifiedM12 (FKA Microsoft Ventures)unverified | The Next Web |
| Apr 7, 2026 | Hermeus | Series C | Participated | $350M | — | Khosla VenturesunverifiedCanaan PartnersunverifiedFounders FundunverifiedBling CapitalunverifiedIn-Q-TelunverifiedPinegrove Venture PartnersunverifiedRTX VenturesSocium VenturesSVBHercules+1 more | TechCrunch |
Sector / Stage Activity
Co-Investors
10Similar Firms
overlapping sector, stage or regionLatest Pulse
- Sep 9, 2026Solstice Oncology Launches With $225M Series ASolstice Oncology launched with a $225 million Series A led by RA Capital Management to advance porustobart, a second-generation CTLA-4 immunotherapy licensed from Harbour BioMed, into two Phase 2 cancer trials.→
- Jul 29, 2026Mate Security Tops $50M as AI Security Ops Heads to Black HatMate Security, founded by former SentinelOne and Wiz leaders, closed a $35 million Series A led by Canaan Partners, pushing its total funding past $50 million as it heads to Black Hat USA.→
Canaan Partners FAQ
What companies has Canaan Partners invested in?
Canaan Partners' portfolio includes Solstice Oncology, Mate Security, Hermeus.
Who does Canaan Partners co-invest with most?
In the rounds Value Add tracks, Canaan Partners most often invests alongside Bling Capital (1 shared deal), Forbion (1 shared deal), Founders Fund (1 shared deal), In-Q-Tel (1 shared deal), Insight Partners (1 shared deal).
Sources & methodologyshow
- GlobeNewswireprimary source1 fact
- TechCrunchmajor outlet1 fact
- The Next WebValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.